Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel
NCT01314235 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2011-03-14
Summary
Clonidin works as a presynaptic agonist of alpha-sympathomimetic receptors of the brain but also in many other tissues. It is part of balanced anesthesia in general anesthesiology as well as a sedastive agent in intensive care units, but also serves as a third-line agent in many psychiatric diseases including ADHD, schizophrenia and PTSD.
The investigators want to show whether clonidin has an procoagulatoric effect on thrombozytes of patients under double anticoagulaotirc treatment with ASS and clopidogrel. The investigators will use a flowcytometric assay to determine activation of thrombozytes when they come into contact with clonidine in vitro as well as Multiplate analyses to determine activation of thrombozytes, either thrombin.induced aggregation, ADP-induced aggregation or arachidonic acid-induced aggregation of thrombozytes.
Conditions
- Anticoagulation
Sponsors & Collaborators
-
Goethe University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
Countries
- Germany
Study Locations
More Related Trials
-
Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
NCT01330589 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition
NCT00302913 ·Status: COMPLETED ·Phase: NA
-
Clopidogrel and Aspirin Interaction Study-2
NCT01341964 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Varenicline on the Antiplatelet Action of Clopidogrel
NCT01308671 ·Status: UNKNOWN ·Phase: NA
-
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
NCT03385538 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
NCT06198673 ·Status: NOT_YET_RECRUITING
-
Mechanistic Study of Anti-Platelet Therapy in Atherosclerosis
NCT07169513 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Resistance to Antithrombotic Therapy
NCT00858715 ·Status: COMPLETED ·Phase: NA
-
GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
NCT01813435 ·Status: COMPLETED ·Phase: PHASE3
-
Anticoagulation in Stent Intervention
NCT01141153 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT00404781 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Reactivity in Stent Thrombosis Patients
NCT01012544 ·Status: COMPLETED ·Phase: PHASE4
-
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01339026 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT02554721 ·Status: COMPLETED ·Phase: PHASE1
-
Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting
NCT01449617 ·Status: UNKNOWN
-
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
NCT03431142 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Analysis in Head Trauma: ASA/Plavix
NCT01534117 ·Status: COMPLETED ·Phase: NA
-
Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery
NCT01146301 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of the Athero-Protective Effects of Clopidogrel
NCT01283282 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
NCT00728156 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
NCT01203696 ·Status: COMPLETED ·Phase: PHASE4
-
Clopidogrel Resistance in Stroke Patients From Different Ethnicities
NCT03806894 ·Status: UNKNOWN
-
The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
NCT02411903 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
NCT01263093 ·Status: COMPLETED ·Phase: PHASE1